Literature DB >> 15819807

Assignment of steatotic livers by the Mayo model for end-stage liver disease.

Javier Briceño1, Javier Padillo, Sebastián Rufián, Guillermo Solórzano, Carlos Pera.   

Abstract

Prognosis after liver transplantation depends on a combination of recipient and donor variables. The purpose of this study is to define an allocation system of steatotic donor livers relative to recipient model for end-stage liver disease (MELD) score. We reviewed 500 consecutive OLT, computing the MELD score for each recipient. Fatty infiltration in grafts was categorized in no steatosis, 10-30%, 30-60% and > or = 60% steatosis. MELD score did not affect preservation injury and graft dysfunction, which were increased with fat content. Recipient and graft survivals lowered when increasing MELD score. Outcome in low-risk recipients (MELD < or = 9) was not altered with steatosis, except those with > or = 60%. Survival functions in moderate-risk recipients (MELD 10-19) were moderately affected with 10-30% steatosis and severely with those with >30. Exactly 30-60% steatotic grafts work poorly in high-risk recipients (MELD > or = 20), and very poorly with > or = 60% steatosis. Prognosis of candidates is optimally influenced when divergence of recipient-donor risks is presented.

Entities:  

Mesh:

Year:  2005        PMID: 15819807     DOI: 10.1111/j.1432-2277.2005.00091.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  15 in total

1.  Deceased donor liver transplant: Experience from a public sector hospital in India.

Authors:  Viniyendra Pamecha; Deeplaxmi Purushottam Borle; Senthil Kumar; Kishore Gurumoorthy Subramanya Bharathy; Piyush Kumar Sinha; Shridhar Vasantrao Sasturkar; Vibuti Sharma; Chandra Kant Pandey; Shiv Kumar Sarin
Journal:  Indian J Gastroenterol       Date:  2017-11-29

2.  Results of a newborn liver transplant program in the era of piggyback technique and extended donor criteria in Italy.

Authors:  Giuseppe Maria Ettorre; Roberto Santoro; Giovanni Vennarecci; Pasquale Lepiane; Mario Antonini; Eugenio Santoro
Journal:  Updates Surg       Date:  2011-07-19

3.  Hepatic steatosis is not always a contraindication for cadaveric liver transplantation.

Authors:  Jan P Deroose; Geert Kazemier; Pieter Zondervan; Jan N M Ijzermans; Herold J Metselaar; Ian P J Alwayn
Journal:  HPB (Oxford)       Date:  2011-04-07       Impact factor: 3.647

4.  Clear mortality gap caused by graft macrosteatosis in Chinese patients after cadaveric liver transplantation.

Authors:  Zhengtao Liu; Wenchao Wang; Li Zhuang; Jingfeng Liu; Shuping Que; Dan Zhu; Linfang Dong; Jian Yu; Lin Zhou; Shusen Zheng
Journal:  Hepatobiliary Surg Nutr       Date:  2020-12       Impact factor: 7.293

5.  A Simple Rapid Method for Measuring Liver Steatosis Using Bioelectrical Impedance.

Authors:  Tomoko Yoshimoto-Haramura; Takanobu Hara; Akihiko Soyama; Tota Kugiyama; Hajime Matsushima; Kunihito Matsuguma; Hajime Imamura; Takayuki Tanaka; Tomohiko Adachi; Masaaki Hidaka; Shuichi Okabe; Masakazu Murata; Susumu Eguchi
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

6.  How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology?

Authors:  Marco Carbone; Jan Lerut; James Neuberger
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 7.  Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review.

Authors:  Michael J J Chu; Anna J Dare; Anthony R J Phillips; Adam S J R Bartlett
Journal:  J Gastrointest Surg       Date:  2015-04-28       Impact factor: 3.452

8.  Influence of Kupffer cells and platelets on ischemia-reperfusion injury in mild steatotic liver.

Authors:  Koichi Ogawa; Tadashi Kondo; Takafumi Tamura; Hideki Matsumura; Kiyoshi Fukunaga; Tatsuya Oda; Nobuhiro Ohkohchi
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

9.  Strategies to reduce hepatitis C virus recurrence after liver transplantation.

Authors:  Ruben Ciria; María Pleguezuelo; Shirin Elizabeth Khorsandi; Diego Davila; Abid Suddle; Hector Vilca-Melendez; Sebastian Rufian; Manuel de la Mata; Javier Briceño; Pedro López Cillero; Nigel Heaton
Journal:  World J Hepatol       Date:  2013-05-27

10.  Syndecan-4 promotes vascular beds formation in tissue engineered liver via thrombospondin 1.

Authors:  Xiaoyi Hu; Junjie Chen; Hechen Huang; Shengyong Yin; Shusen Zheng; Lin Zhou
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.